Literature DB >> 36271952

Construction of a combined random forest and artificial neural network diagnosis model to screening potential biomarker for hepatoblastoma.

Shaowen Liu1, Qipeng Zheng1, Ruifeng Zhang1, Tengfei Li1, Jianghua Zhan2,3.   

Abstract

PURPOSE: The purpose of our study is to identify potential biomarkers of hepatoblastoma (HB) and further explore the pathogenesis of it.
METHODS: Differentially expressed genes (DEGs) were incorporated into the combined random forest and artificial neural network diagnosis model to screen candidate genes for HB. Gene set enrichment analysis (GSEA) was used to analyze the ARHGEF2. Student's t test was performed to evaluate the difference of tumor-infiltrating immune cells (TIICs) between normal and HB samples. Spearson correlation analysis was used to calculate the correlation between ARHGEF2 and TIICs.
RESULTS: ARHGEF2, TCF3, TMED3, STMN1 and RAVER2 were screened by the new model. The GSEA of ARHGEF2 included cell cycle pathway and antigen processing presenting pathway. There were significant differences in the composition of partial TIICs between HB and normal samples (p < 0.05). ARHGEF2 was significantly correlated with memory B cells (Cor = 0.509, p < 0.05).
CONCLUSION: These 5 candidate genes contribute to the molecular diagnosis and targeted therapy of HB. And we found "ARHGEF2-RhoA-Cyclin D1/CDK4/CDK6-EF2" is a key mechanism regulating cell cycle pathway in HB. This will be helpful in the treatment of HB. The occurrence of HB is related to abnormal TIICs. We speculated that memory B cells play an important role in HB.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Artificial neural network; Hepatoblastoma; Molecular diagnosis; Potential biomarker; Random forest; Tumor-infiltrating immune cell

Year:  2022        PMID: 36271952     DOI: 10.1007/s00383-022-05255-3

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   2.003


  30 in total

Review 1.  Contemporary management of hepatoblastoma.

Authors:  Einar Hafberg; Scott C Borinstein; Sophoclis P Alexopoulos
Journal:  Curr Opin Organ Transplant       Date:  2019-04       Impact factor: 2.640

2.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

3.  pROC: an open-source package for R and S+ to analyze and compare ROC curves.

Authors:  Xavier Robin; Natacha Turck; Alexandre Hainard; Natalia Tiberti; Frédérique Lisacek; Jean-Charles Sanchez; Markus Müller
Journal:  BMC Bioinformatics       Date:  2011-03-17       Impact factor: 3.307

4.  GoPubMed: exploring PubMed with the Gene Ontology.

Authors:  Andreas Doms; Michael Schroeder
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

5.  Pathview: an R/Bioconductor package for pathway-based data integration and visualization.

Authors:  Weijun Luo; Cory Brouwer
Journal:  Bioinformatics       Date:  2013-06-04       Impact factor: 6.937

Review 6.  Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma.

Authors:  Ying-Li Sha; Shuang Liu; Wen-Wen Yan; Bo Dong
Journal:  Biosci Rep       Date:  2019-09-24       Impact factor: 3.840

7.  m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma.

Authors:  Li Liu; Jing Wang; Guifeng Sun; Qiong Wu; Ji Ma; Xin Zhang; Nan Huang; Zhixuan Bian; Song Gu; Min Xu; Minzhi Yin; Fenyong Sun; Qiuhui Pan
Journal:  Mol Cancer       Date:  2019-12-23       Impact factor: 27.401

8.  GSVA: gene set variation analysis for microarray and RNA-seq data.

Authors:  Sonja Hänzelmann; Robert Castelo; Justin Guinney
Journal:  BMC Bioinformatics       Date:  2013-01-16       Impact factor: 3.169

Review 9.  Hepatoblastoma: current understanding, recent advances, and controversies.

Authors:  Piotr Czauderna; Hanna Garnier
Journal:  F1000Res       Date:  2018-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.